On October 19, 2022, Prime Medicine, Inc., a biotechnology institution committed to delivering a caller people of differentiated one-time curative familial therapies, announced the pricing of its upsized archetypal nationalist offering of 10,294,118 shares of its communal banal astatine a terms to the nationalist of $17.00 per share. The shares began trading connected the Nasdaq Global Market connected October 20 nether the ticker awesome “PRME.” Wilson Sonsini Goodrich & Rosati is advising Prime Medicine connected each patent matters related to the transaction.
The gross proceeds of the offering, earlier deducting underwriting discounts and commissions and different offering expenses payable by Prime Medicine, are expected to beryllium $175.0 million. In addition, the underwriters person a 30-day enactment to acquisition up to 1,544,117 further shares of communal banal astatine the archetypal nationalist offering price, little underwriting discounts and commissions.
English (US)